Alexander Bisignano serves as the Chief Executive Officer for Recombine. Alex is a seasoned computer programmer with experience developing complex web applications and providing high-end bioinformatic solutions for molecular genetic data. As CEO, Alex is responsible for developing and managing Recombine’s core technology while executing on broad business strategy. Prior to his work in genomics, Alex worked at Credit Suisse where he was responsible for improving the performance of large internal database systems. Alex received his B.A. in molecular biology from Princeton University.
Powering Research Through the Clinic
Recombine is a biotechnology company powered by experts in fertility, genetics, and computer science. Our mission is to expand the scope and impact of genomics in medicine, through innovative products, dedicated patient care, and collaborative research.